Beranda › Limfoma Sel Mantel › Ohio › Columbus
Uji klinis Limfoma Sel Mantel di Columbus, OH
11 studi untuk Limfoma Sel Mantel mencari peserta di lokasi sekitar Columbus (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
Menerima pesertaFase 3
- Ohio State University Comprehensive Cancer Center, Columbus
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
Menerima pesertaFase 3
- Ohio State University Comprehensive Cancer Center, Columbus
- Ohio Health Research Institute, Columbus
Testing the Anti-cancer Drug, Glofitamab, in Patients With Mantle Cell Lymphoma (A Type of Blood Cancer) Whose Disease Returned After CAR-T Cell Therapy
Menerima pesertaFase 2
- Ohio State University Comprehensive Cancer Center, Columbus
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
Menerima pesertaFase 1/2
- Research Site, Columbus
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Menerima pesertaFase 1/2
- The Ohio State University Wexner Medical Center, Columbus
DALY II USA/ MB-CART2019.1 for DLBCL
Menerima pesertaFase 2
- The Ohio State University Wexner Medical Center James Cancer, Columbus
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
Menerima pesertaFase 1/2
- The Ohio State University Comprehensive Cancer Center, Columbus
Study of SGR-1505 in Mature B-Cell Neoplasms
Menerima pesertaFase 1
- The Ohio State University - The James Cancer Hospital, Columbus
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
Menerima pesertaFase 1
- Ohio State University, Columbus
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Columbus
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
Menerima pesertaFase 1
- The Ohio State University - The James Cancer Hospital and Solove Research Institute, Columbus
Uji klinis Limfoma Sel Mantel di kota lain
- Baldwin Park, CA15 studi
- Houston, TX15 studi
- Durham, NC13 studi
- New York City, NY12 studi
- Seattle, WA12 studi
- Milwaukee, WI12 studi
- Boston, MA11 studi
- Nashville, TN11 studi
- Chicago, IL10 studi
- Portland, OR9 studi
- Rochester, MN9 studi
- St. Louis, MO8 studi
Studi lain di Columbus
- Kanker Paru Non-Sel Kecil56 studi
- Kanker Payudara39 studi
- Kanker Ovarium39 studi
- Kanker (semua jenis)38 studi
- Kanker Paru37 studi
- Leukemia Mieloid Akut35 studi
- Leukemia Limfositik Kronis28 studi
- Kanker Metastatik27 studi
- Kanker Endometrium25 studi
- Kanker Kolorektal24 studi
- Kanker Prostat24 studi
- Mieloma Multipel24 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.